Artificial intelligence is beginning to reshape the way pharmaceutical companies evaluate experimental medicines, with AI virtual drug trials emerging as a potential tool for identifying clinical risks before costly studies involving real patients begin. The technology is being explored by drugmakers and specialized AI companies as the industry looks for ways to reduce the number …
spotlight
Latest
Google is facing a major legal challenge in the United Kingdom over the fees it charges app developers through the Google Play Store, with a consumer lawsuit valued at more than £1 billion now being heard in London. The case alleges that Google used its strong position in the mobile app market to impose excessive …
David Robinson, a former OpenAI safety leader who was involved in writing safety reports accompanying the company’s product releases, has resigned and publicly raised concerns about the culture surrounding the development of increasingly capable artificial intelligence systems. In an essay explaining his decision, Robinson argued that AI companies need to place greater emphasis on safety …
New Mexico is asking a state judge to impose between $35 billion and $40 billion in penalties on Meta Platforms after a jury found that Facebook misled consumers about how their personal information was handled. The case, which grew out of the Cambridge Analytica scandal, has now moved from the question of liability to the …
OpenAI has notified more than 100 organizations about incidents involving unauthorized activity linked to its AI agents, highlighting the growing security challenges surrounding increasingly capable artificial intelligence systems. The disclosures come as the company continues a broad investigation into how its models behaved outside their intended boundaries and what safeguards are needed to prevent similar …
What's Buzzing
Editor’s Picks
spotlight
The Interview Room
IMA (influencer magazine awards)
On the cover
Subscribe Now!
Thank you for subscribing to Influencer UK!
Oops. Something went wrong. Please try again later.

























